Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1956 2
1957 1
1963 6
1964 1
1965 2
1966 3
1967 5
1968 4
1969 5
1970 1
1972 1
1973 2
1975 1
1976 3
1977 4
1978 2
1979 6
1980 6
1981 9
1982 16
1983 8
1984 13
1985 14
1986 8
1987 19
1988 18
1989 35
1990 21
1991 26
1992 23
1993 35
1994 36
1995 27
1996 29
1997 33
1998 35
1999 37
2000 37
2001 41
2002 22
2003 40
2004 38
2005 34
2006 37
2007 46
2008 50
2009 48
2010 50
2011 58
2012 56
2013 69
2014 61
2015 54
2016 43
2017 49
2018 75
2019 91
2020 88
2021 111
2022 112
2023 101
2024 96
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,859 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: the FRAGILE-HF cohort study.
Matsue Y, Kamiya K, Saito H, Saito K, Ogasahara Y, Maekawa E, Konishi M, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Yonezawa R, Oka K, Momomura SI, Kagiyama N. Matsue Y, et al. Among authors: oka k. Eur J Heart Fail. 2020 Nov;22(11):2112-2119. doi: 10.1002/ejhf.1926. Epub 2020 Jul 14. Eur J Heart Fail. 2020. PMID: 32500539 Free article.
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.
Dizman N, Meza L, Bergerot P, Alcantara M, Dorff T, Lyou Y, Frankel P, Cui Y, Mira V, Llamas M, Hsu J, Zengin Z, Salgia N, Salgia S, Malhotra J, Chawla N, Chehrazi-Raffle A, Muddasani R, Gillece J, Reining L, Trent J, Takahashi M, Oka K, Higashi S, Kortylewski M, Highlander SK, Pal SK. Dizman N, et al. Among authors: oka k. Nat Med. 2022 Apr;28(4):704-712. doi: 10.1038/s41591-022-01694-6. Epub 2022 Feb 28. Nat Med. 2022. PMID: 35228755 Free PMC article. Clinical Trial.
Targeting site-specific chromosome integration.
Nuno-Gonzalez P, Chao H, Oka K. Nuno-Gonzalez P, et al. Among authors: oka k. Acta Biochim Pol. 2005;52(2):285-91. Epub 2005 Jun 3. Acta Biochim Pol. 2005. PMID: 15940345 Free PMC article. Review.
Pseudoacromegaly with acromegalic features in radiography.
Yamamoto K, Oka K, Honda H, Hasegawa K, Otsuka F. Yamamoto K, et al. Among authors: oka k. Clin Case Rep. 2021 May 15;9(5):e04095. doi: 10.1002/ccr3.4095. eCollection 2021 May. Clin Case Rep. 2021. PMID: 34026138 Free PMC article.
Acute Pancreatitis Related to COVID-19 Infection.
Yamamoto K, Oka K, Sakae H, Otsuka F. Yamamoto K, et al. Among authors: oka k. Intern Med. 2021 Jul 1;60(13):2159-2160. doi: 10.2169/internalmedicine.7400-21. Epub 2021 May 14. Intern Med. 2021. PMID: 33994442 Free PMC article. No abstract available.
Lysinibacillus fusiformis bacteremia: Case report and literature review.
Morioka H, Oka K, Yamada Y, Nakane Y, Komiya H, Murase C, Iguchi M, Yagi T. Morioka H, et al. Among authors: oka k. J Infect Chemother. 2022 Feb;28(2):315-318. doi: 10.1016/j.jiac.2021.10.030. Epub 2021 Dec 2. J Infect Chemother. 2022. PMID: 34865964 Review.
1,859 results